![Richard Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Jones
Vorstandsvorsitzender bei AdrenoMed AG
Aktive Positionen von Richard Jones
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AdrenoMed AG
![]() AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | 15.03.2022 | - |
Karriereverlauf von Richard Jones
Ehemalige bekannte Positionen von Richard Jones
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FUSION ANTIBODIES PLC | Direktor/Vorstandsmitglied | 16.02.2021 | 11.03.2022 |
Vorstandsvorsitzender | 16.02.2021 | 11.03.2022 | |
BrYet Ltd. | Direktor/Vorstandsmitglied | 01.04.2020 | 01.07.2020 |
Vorstandsvorsitzender | 01.04.2020 | 01.07.2020 | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
Novartis UK Ltd.
![]() Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - | - |
Holostem Terapie Avanzate S R L | Vorstandsvorsitzender | - | - |
Akcea Therapeutics UK Ltd. | Corporate Officer/Principal | - | - |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Vorstandsvorsitzender | 27.01.2016 | - |
Ausbildung von Richard Jones
University of Surrey | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Vereinigte Staaten | 2 |
Schweden | 2 |
Operativ
Chief Executive Officer | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
FUSION ANTIBODIES PLC | Health Services |
Private Unternehmen | 7 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Novartis UK Ltd.
![]() Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
Akcea Therapeutics UK Ltd. | |
BrYet Ltd. | |
Holostem Terapie Avanzate S R L | |
AdrenoMed AG
![]() AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Börse
- Insiders
- Richard Jones
- Erfahrung